Michael Leahy

7.4k citations
71 papers · 3.5k · 3 hit papers · h-index 27

Impact in

Papers in

    • Sarcoma Diagnosis and Treatment 23
    • Gastric Cancer Management and Outcomes 5
    • Bladder and Urothelial Cancer Treatments 5
    • Cholangiocarcinoma and Gallbladder Cancer Studies 4
    • Gastrointestinal disorders and treatments 4

Michael Leahy

68 papers receiving 3.4k citations

Michael Leahy's Hit Papers

Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial 2017 · 345 citations
3450+5+10Years since publication100200300400500

Peers

Michael Leahy
Comparison fields: 5 of 110
  • Pulmonary and Respiratory Medicine 1.7k
  • Oncology 1.2k
  • Gastroenterology 215
  • Surgery 974
  • Rheumatology 266
Replace Antonio López–Pousa with:
Antonio López–Pousa Spain
Charlotte Benson United Kingdom
Xavier García del Muro Spain
Myles Smith United Kingdom
Brian L. Samuels United States
A.M. Mandard France
Isabelle Ray‐Coquard France
Rashmi Chugh United States
Mrinal M. Gounder United States
Dominique Ranchère‐Vince France
Michael Leahy relative to Antonio López–Pousa Spain Antonio López–Pousa's profile →
Citations per field
00.5×1.5×2.2×
Antonio López–Pousa · 1×
Citations per year

Countries citing papers authored by Michael Leahy

Since Specialization
Citations

This map shows the geographic impact of Michael Leahy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Leahy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Leahy more than expected).

Fields of papers citing papers by Michael Leahy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Leahy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Leahy. The network helps show where Michael Leahy may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Leahy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Leahy Line = papers co-authored together Michael Leahy links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Randomized Phase II/III Trial Assessing Gemcitabine/Carboplatin and Methotrexate/Carboplatin/Vinblastine in Patients With Advanced Urothelial Cancer Who Are Unfit for Cisplatin-Based Chemotherapy: EORTC Study 30986
Hit paper breakdown →
2011536
2
Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial
Hit paper breakdown →
2012389
3
Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial
Hit paper breakdown →
2017345
4 2011254
5 1999219
6 2007191
7 2018125
8 2009124
9 2014119
10 201490
11 201085
12 200879
13 201966
14 201257
15 199753
16 201252
17 201447
18 201544
19 200942
20 202141

About Michael Leahy

Michael Leahy is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Gastroenterology, Oncology and Cancer Research, having authored 71 papers that have together received 3.5k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (23 papers), Gastrointestinal Tumor Research and Treatment (16 papers), Bladder and Urothelial Cancer Treatments (5 papers), Gastric Cancer Management and Outcomes (5 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers), Gastrointestinal disorders and treatments (4 papers), Cancer Genomics and Diagnostics (4 papers) and Neurofibromatosis and Schwannoma Cases (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.7k citations), Oncology (1.2k citations), Gastroenterology (215 citations), Surgery (974 citations) and Rheumatology (266 citations). Michael Leahy has collaborated with scholars based in United Kingdom, France and Netherlands. Frequent co-authors include Sandrine Marréaud, Jean‐Yves Blay, J. Martijn Kerst, Jaap Verweij, Pancras C.W. Hogendoorn, Axel Le Cesne, Richard Sylvester, Maria De Santis, Pablo Maroto and Graham M. Mead. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Annals of Oncology, British Journal of Cancer and Sarcoma.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact